comparemela.com

Page 7 - Nirma Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Glenmark Life Sciences shares hit Rs 600 level on reports Nirma, others in race to buy API maker

Glenmark Pharmaceuticals that owns 82.85 per cent stake in Glenmark Life Sciences may sell the API developer and manufacturer in bid to deleverage, as per the report.

Samarskaya oblastSekhmet pharmaventuresGlenmark life sciencesGlenmark life sciences ltdNirma groupGlenmark pharmaceuticals ltdGlenmark lifeBofa securitiesNeuland laboratoriesAarti drugsSolara active pharma

Morning Scan: All the big stories to get you started for the day

A round-up of top newspaper stories to keep you ahead of others

Republic ofSamarskaya oblastTamil naduGlenn saldanhaSekhmet pharmaventuresPiyush goyalAyushman bharat digital missionNational company law tribunalGlenmark pharmaceuticalsNirma groupNational bankBrookfield infrastructure partnersBank niftyIndian cellular electronics association of indiaAyushman bharat health account abha idsDevelopment authority of india

Grapevine: PE-backed Sekhmet in fray for Glenmark s arm; Easebuzz to raise fresh funding

Grapevine: PE-backed Sekhmet in fray for Glenmark s arm; Easebuzz to raise fresh funding
vccircle.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from vccircle.com Daily Mail and Mail on Sunday newspapers.

Samarskaya oblastSekhmet pharmaventuresGlenmark pharmaNirma groupAhmedabad based nirma groupSamara capital

Sanghi Cement receives further offers to acquire stake

Sanghi Cement receives further offers to acquire stake

Nirma groupJk organisationEconomic timesSanghi cement

InvAscent invests in bootstrapped healthcare firm from third fund

InvAscent, a homegrown private equity firm focused on healthcare bets across the country, has struck a fresh investment in a diagnostics firm from its latest ..

Hari bugganaIndia life sciences fundInvascent indiaGeneral diagnosticsKedaara capitalNirma groupHealthcare servicesAnuj suvarnaPrivate equity

vimarsana © 2020. All Rights Reserved.